{"nct_id":"NCT03809624","title":"Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer","status":"TERMINATED","status_verified_date":"2024-10","start_date":"2019-01-30","start_date_type":"ACTUAL","primary_completion_date":"2024-10-03","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["INBX"]}